Alpha Modus (AMOD)resolved its patent infringement litigation against Brookshire Grocery Co. pending in the United States District Court for the Eastern District of Texas. The litigation involved ...
Novo dropped its patent-infringement case against telehealth provider Hims & Hers after the companies agreed that Hims would sell Novo's branded medicines.
First Solar has filed a Sec. 337 investigation request with the U.S. International Trade Commission (ITC) on a swath of crystalline silicon panel ...
Moderna Inc.’s settlement to end a lawsuit over technology used in its Covid-19 vaccine caps its potential exposure at $2.25 ...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of ...
Facial recognition and license plate reading tools that Immigration and Customs Enforcement and other Department of Homeland Security personnel are using in sweeps infringe five patents owned by a ...
Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If ...
MARSHALL, Texas, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Alpha Modus, Corp., the subsidiary of Alpha Modus Holdings, Inc. (NASDAQ: AMOD), an innovator in AI-driven retail analytics and behavioral ...
The Federal Circuit recently issued a significant decision in the ongoing patent litigation between Laboratory Corporation of America Holdings (Labcorp) and Qiagen Sciences, LLC, reversing a Delaware ...
The Federal Circuit’s recent decision in Range of Motion Products, LLC v. Armaid Company Inc. highlights a growing dissatisfaction with courts’ broad use of the sufficiently distinct/plainly ...
Corcept Therapeutics lost its patent-infringement battle with Teva Pharmaceutical Industries, exposing Corcept to more competition from generic drugs. The ruling from the U.S. Court of Appeals for the ...
Bruce Huang of Saint Island International Patent & Law Offices explains how the Intellectual Property and Commercial Court and the Supreme Court have recently clarified limits on generic drug skinny-l ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results